Lifecycle Management

(Image: Getty/Elen11)

The scale of generic uptake in the major markets

By Ben Hargreaves

The divergence across global market penetration of generic medicines is broad, with some countries’ markets worth close to half of the entire sector or as low as one fifth, according to IGBA.

(Image: Getty/Klebercordeiro)

Lilly expands migraine offerings after FDA approval

By Ben Hargreaves

US FDA gives marketing authorization to Lilly’s oral medication for the acute treatment of migraines in adult patients, adding to its Emgality approval almost exactly a year ago.

(Image: Getty/Kevron2001)

FDA aims to speed naloxone generics to market

By Ben Hargreaves

US FDA follows up the first generic approval of naloxone nasal spray by encouraging companies to apply with generic applications amid the North American opioid crisis.

Follow us

Products

View more

Webinars